Inmed pharmaceuticals reports third quarter fiscal 2021 financial results

Vancouver, british columbia, may 13, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq:inm), a clinical-stage company developing pharmaceutical-based drug candidates and leading the way in the clinical development of cannabinol (“cbn”), today reported financial results for the third quarter of fiscal year 2021 (“3q21”) which ended march 31, 2021.
INM Ratings Summary
INM Quant Ranking